Health Products Regulatory Authority, Ireland (HPRA) and UK MHRA have carried out joint Inspection of Shendra, Aurangabad facility of the Wockhardt. HPRA has granted GMP Certificate to Shendra, Aurangabad facility of the company which is valid for a period of three years i.e. up to January 31, 2022.
Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.
